Trademark: 87091052
Word
XIROMED
Status
Registered
Status Code
700
Status Date
Tuesday, December 28, 2021
Serial Number
87091052
Registration Number
6603289
Registration Date
Tuesday, December 28, 2021
Mark Type
5000
Filing Date
Friday, July 1, 2016
Published for Opposition
Tuesday, August 30, 2016

Trademark Owner History
INSUD PHARMA, S.L.U. - Original Registrant
CHEMO ESPAÑA. S.L. - Owner At Publication

Classifications
5 Pharmaceutical preparation for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, psychiatric diseases, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments; all of the foregoing excluding pharmaceutical preparations for the treatment and/or management of sleep disorders, narcolepsy, cataplexy, and/or excessive daytime sleepiness (EDS); veterinary preparation for treating digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments; all of the foregoing excluding pharmaceutical preparations for the treatment and/or management of sleep disorders, narcolepsy, cataplexy, and/or excessive daytime sleepiness (EDS)
35 Sales promotion for others, business management assistance, business management consultancy and market research; presentation of goods by any means of communications for retailing purposes; commercial administration of the licensing of the goods and services of others; organisation of exhibitions, trade fairs or congresses for commercial or advertising purposes; all the aforesaid in this class relating to pharmaceutical businesses and for pharmaceutical preparations
The color(s) blue and gray is/are claimed as a feature of the mark.
The mark consists of the words "XIROMED" in stylized capital letters, the color blue appears in the upper section of the letter "X" and the color gray appears in the lower section of the letter "X" and in the letters "IROMED".
The wording "XIROMED" has no meaning in a foreign language.

Trademark Events
Dec 28, 2021
Registered-Principal Register
Nov 23, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 22, 2021
Allowed Principal Register - Sou Accepted
Nov 9, 2021
Statement Of Use Processing Complete
Sep 23, 2021
Use Amendment Filed
Oct 6, 2021
Case Assigned To Intent To Use Paralegal
Sep 23, 2021
Teas Statement Of Use Received
Sep 14, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 14, 2021
Teas Change Of Correspondence Received
Sep 14, 2021
Teas Change Of Domestic Representatives Address
Sep 14, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 14, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 14, 2021
Teas Change Of Owner Address Received
Apr 20, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 5, 2021
Ttab Release Case To Trademarks
Mar 5, 2021
Opposition Terminated No. 999999
Mar 5, 2021
Opposition Dismissed No. 999999
Jan 16, 2019
Assignment Of Ownership Not Updated Automatically
Feb 27, 2017
Opposition Instituted No. 999999
Jan 27, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 27, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 28, 2016
Extension Of Time To Oppose Received
Aug 30, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2016
Published For Opposition
Aug 10, 2016
Notification Of Notice Of Publication E-Mailed
Jul 26, 2016
Law Office Publication Review Completed
Jul 22, 2016
Assigned To Lie
Jul 11, 2016
Approved For Pub - Principal Register
Jul 11, 2016
Examiner's Amendment Entered
Jul 11, 2016
Notification Of Examiners Amendment E-Mailed
Jul 11, 2016
Examiners Amendment E-Mailed
Jul 11, 2016
Examiners Amendment -Written
Jul 6, 2016
Assigned To Examiner
Jul 6, 2016
New Application Office Supplied Data Entered In Tram
Jul 5, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24